This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
September 23-26, 2024
Hynes Convention CenterBoston, MA

Eris Jordan
Global Vice President, Clinical and Medical Affairs at Aurion Biotech


Eris Jordan, OD, is Global Vice President for Clinical and Medical Affairs at Aurion Biotech, a clinical-stage cell therapy company whose mission is to restore vision to millions of patients with life-changing regenerative therapies. She is responsible for clinical trial strategy, development and execution. In addition, she manages relationships with Aurion Biotech’s medical advisors, KOLs and clinical trial investigators. She provides strategic and tactical support to the company’s scientific, clinical and regulatory teams. Before transitioning to the ophthalmic industry, she spent a decade providing direct patient care and serving as a clinic director for a cornea and anterior segment surgical practice, and continues to see patients in her practice.

Agenda Sessions

  • Building a mass-scale cell therapy for corneal endothelial disease